Immunohistochemistry has become an essential component of breast cancer pathology, toevaluate for expression of the two hormone receptors, estrogen receptor (ER) andprogesterone receptor (PR), as well as the human epidermal growth factor receptor 2(HER2/neu). This evidence concerns the gene ERBB2 and breast cancer.